A detailed history of N Verses Capital, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 700 shares of ARWR stock, worth $15,379. This represents 0.01% of its overall portfolio holdings.

Number of Shares
700
Previous 3,700 81.08%
Holding current value
$15,379
Previous $96.2 Million 85.9%
% of portfolio
0.01%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$19.36 - $29.54 $58,080 - $88,620
-3,000 Reduced 81.08%
700 $13.6 Million
Q2 2024

Jul 31, 2024

BUY
$21.87 - $28.24 $80,919 - $104,488
3,700 New
3,700 $96.2 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.33B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.